Canopy Growth Corporation (CGC)

Over the past six months, Canopy Growth's stock price has been influenced by several events. The company reported its Q2 2026 and Q3 2026 earnings, with Q3 showing a reduced net loss compared to the previous year, although EPS lagged analyst expectations. News of potential cannabis reclassification in the U.S. led to rallies in cannabis stocks, including CGC, with a significant price increase following news from the Trump administration. Canopy Growth completed the acquisition of MTL Cannabis in March 2026, aiming to strengthen its position in the Canadian medical cannabis market.

Canopy Growth has observed seasonal demand for its Storz & Bickel vaporization devices, with strong demand during Q3 FY2026.

Canopy Growth Corporation is a Canadian cannabis company involved in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical use. The company operates within the medicinal and botanical manufacturing segment, aiming to improve lives through a global cannabis platform. Canopy Growth offers a diverse product portfolio, including dried cannabis flower, infused pre-roll joints, cannabis oils, softgel capsules, cannabis vapes, beverages, and edibles, under various owned and licensed brands.

Canopy Growth's primary operations are in Canada, Europe, and Australia, serving medical cannabis patients globally. In Canada, it participates in both medical and adult-use markets. The company supplies medical cannabis products in European markets and Australia, with partnerships in Spain, a subsidiary in Germany, and business involvement in Jamaica, Chile, Peru, and Brazil. Canopy Growth has also established a presence in the United States through joint ventures and investments, providing indirect exposure to the U.S. THC market via Canopy USA's holdings.

In the past year, Canopy Growth has focused on brand innovation and market presence. Apollo Cannabis Clinics were named "Best Medical Cannabis Clinic" in the 2025 Toronto Star's Readers' Choice Awards. The company unveiled a new cannabis brand called "Deelish" targeting everyday consumers. Canopy Growth refreshed its Tweed brand with a national summer campaign, including new flower strains and updated packaging. Canopy Growth and Spectrum Therapeutics expanded their Minor Cannabinoid softgel lineup, introducing new pack formats and dosing options.

Canopy Growth Corporation has a mixed ownership structure, including institutional, insider, and retail investors. Major institutional shareholders include Jane Street Group, Llc, Toroso Investments, LLC, Susquehanna International Group, Llp, D. E. Shaw & Co., Inc., Citadel Advisors Llc, and Morgan Stanley. Greenstar II Holdings LLC is the largest individual shareholder. A significant portion of the company's stock is held by public companies and individual (retail) investors.